acetazolamide

Generic: acetazolamide

Labeler: zydus lifesciences limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide
Generic Name acetazolamide
Labeler zydus lifesciences limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acetazolamide 125 mg/1

Manufacturer
Zydus Lifesciences Limited

Identifiers & Regulatory

Product NDC 70771-1827
Product ID 70771-1827_859b8e26-b64c-4d17-adbf-0251745c0510
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211069
Listing Expiration 2026-12-31
Marketing Start 2023-07-15

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707711827
Hyphenated Format 70771-1827

Supplemental Identifiers

RxCUI
197303 197304
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide (source: ndc)
Generic Name acetazolamide (source: ndc)
Application Number ANDA211069 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 125 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (70771-1827-1)
source: ndc

Packages (1)

70771-1827-1 100 TABLET in 1 BOTTLE (70771-1827-1)

Ingredients (1)

acetazolamide (125 mg/1)

Linked Drug Pages (1)

acetaZOLAMIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "859b8e26-b64c-4d17-adbf-0251745c0510", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "unii": ["O3FX965V0I"], "rxcui": ["197303", "197304"], "spl_set_id": ["df84fea3-8947-403f-b470-1eeb6c4c293d"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (70771-1827-1)", "package_ndc": "70771-1827-1", "marketing_start_date": "20230715"}], "brand_name": "acetaZOLAMIDE", "product_id": "70771-1827_859b8e26-b64c-4d17-adbf-0251745c0510", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "70771-1827", "generic_name": "acetaZOLAMIDE", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acetaZOLAMIDE", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "125 mg/1"}], "application_number": "ANDA211069", "marketing_category": "ANDA", "marketing_start_date": "20230715", "listing_expiration_date": "20261231"}